Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Yunjie Duan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-0162-8382; OpenAlex author ID A5029499726. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 4 papers · 2023: 3 papers · 2024: none · 2025: 1 paper

Papers 8

  1. Delayed gastric emptying risk stratification in patients with pancreatic ductal adenocarcinoma after pancreatoduodenectomy: An international validation cohort … Co-author DOI 10.1002/ueg2.12688↗
  2. Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma. Co-author DOI 10.18632/aging.204811↗
  3. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer. Co-author DOI 10.18632/aging.204915↗
  4. Clinicopathological Features, Immune Infiltration Landscape and Involved Signaling Pathways of the desmogleins family in Pancreatic Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-2971625/v1↗
  5. Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2022.887385↗
  6. Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma. Co-author DOI 10.3389/fmolb.2022.1036287↗
  7. Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma. Co-author DOI 10.3389/fmolb.2022.1096679↗
  8. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/ijms231810316↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongxing Du · 8 shared papers, 2022–2025 · strength 1.74
  2. Zongting Gu · 7 shared papers, 2022–2025 · strength 1.55
  3. Xiaohao Zheng · 5 shared papers, 2022–2025 · strength 1.11
  4. Chengfeng Wang · 3 shared papers, 2022–2025 · strength 0.74
  5. Chengfeng Wang · 3 shared papers, 2022–2023 · strength 0.61
  6. Jianwei Zhang · 1 shared paper, 2025 · strength 0.30
  7. Yefeng Yin · 1 shared paper, 2023 · strength 0.20
  8. Chengfeng Wang · 1 shared paper, 2022 · strength 0.20
  9. Xu Che · 1 shared paper, 2023 · strength 0.18
  10. Zhenyu Lin · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.